IntegraGen Logo

IntegraGen

ISIN

FR0010908723

Ticker

ALINT

Sector

Health Care

Sub-Industry

Biotechnology

Country

France

Year Founded

2000

About IntegraGen

Company Description

IntegraGen is an OncoDNA Group company specializing in the genomics of cancer and genetic diseases. Backed by highly competent and qualified teams, IntegraGen is a leading player in genomic services which has been operating sequencing platforms for research institutes of excellence.

IntegraGen's mission is to translate molecular research into clinical practice through the identification of novel genetic biomarkers and the subsequent commercialization of molecular diagnostic tests based on these discoveries. The company also strives to be a leader in providing cutting-edge genomic services to academic researchers and life sciences companies based on the company's technological expertise and scientific know-how.

Headcount

50

Served Area

Worldwide

Headquarters

Genopole Campus 1 - Bâtiment 8 5 Rue de Henri Desbruères
91000, Évry
France

Capital Markets Information

ISIN

FR0010908723

LEI

969500CQD8K0BUIGDH55

Sub-Industry

Biotechnology

Listed Stock Exchange

Euronext Paris

Contact Investor Relations Department

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.